Feliu, J <br/><br/>
Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jan 2011 
 - 215-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1472-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Erlotinib Hydrochloride<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Pancreatic Neoplasms--drug therapy<br/>Quinazolines--administration & dosage<br/>Survival<br/>Treatment Outcome<br/>Gemcitabine